John Lamattina

(Dr. John Lamattina Ph.D.)

Currently holds positions in Ligand Pharmaceuticals Inc and Larimar Therapeutics Inc

Positions

Position Company Period
Independent Director Ligand Pharmaceuticals Inc Feb. 7, 2011 -
Independent Director Larimar Therapeutics Inc None -
Independent Director Human Genome Sciences Inc May 7, 2008 - July 30, 2012
John Lamattina's trades of Ligand Pharmaceuticals Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2024-12-02 2024-11-27
S Sale
2,406 -7.5%
123.65
USD 297,502 		2,406 -7.5% 123.65 USD 297,502
2021-11-17 2021-11-16
S Sale
4,835 -16.0%
161.86
USD 782,579 		4,835 -16.0% 161.86 USD 782,579
2021-05-26 2021-05-24
US Immunome Inc (IMNM)
B Purchase
5,102 +10.9%
18.58
USD 94,795 		5,102 +10.9% 18.58 USD 94,795
2021-05-26 2021-05-24
US Immunome Inc (IMNM)
B Purchase
338 +0.7%
18.44
USD 6,233 		338 +0.7% 18.44 USD 6,233
// ... existing code ... // ... rest of the file ...